Poly(γ-benzyl-L-glutamate)-PEG-alendronate multivalent nanoparticles for bone targeting.

Area of Science:

• Biomaterials Science
• Nanotechnology
• Orthopedic Research

Background:

• Hydroxyapatite (HAP) is a primary component of bone tissue, making it a key target for bone-seeking therapeutics.
• Developing effective bone-targeting strategies is crucial for treating skeletal diseases.
• Nanoparticles offer a platform for enhanced interaction with bone surfaces through multivalency.

Purpose of the Study:

• To engineer and characterize nanoparticles with improved hydroxyapatite (HAP) binding capabilities.
• To investigate the multivalency effect in nanoparticle-HAP interactions for enhanced osteotropicity.
• To explore the potential of these nanoparticles in improving bone targeting for skeletal disease treatment.

Main Methods:

• Nanoparticles composed of PBLG10k-b-PEG6k-alendronate were synthesized using a nanoprecipitation method.
• Isothermal titration calorimetry was employed to determine the calcium affinity of the nanoparticles.
• Fluorescence studies were utilized to quantify the multivalent interaction of nanoparticles with HAP surfaces.

Main Results:

• The synthesized nanoparticles demonstrated a calcium affinity (KCa(+2)) of 1.8 × 10(4)M(-1).
• A significantly strong multivalent interaction with HAP surfaces (KHAP) was estimated at 1.1 × 10(10)M(-1).
• This multivalent interaction is over 4000 times stronger than reported monovalent alendronate-HAP interactions.

Conclusions:

• The engineered nanoparticles exhibit superior binding affinity to HAP compared to monovalent interactions.
• The multivalency effect is key to the enhanced bone-targeting potential of these nanoparticles.
• These findings provide a deeper understanding of bone-targeting carriers and suggest potential improvements for skeletal disease therapeutics.